Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.

British journal of haematology - 1 Feb 2005

Kennedy Margaret, Andreescu Astrid C M, Greenblatt Marc S, Jiang Hongyu, Thomas Christian A, Chassereau Laurie, Wong Cheung, Durda Peter, Cushman Mary

Abstract excerpt

Cancer patients have an increased risk of venous thrombosis (VT). The association of factor V Leiden (FVL) and the prothrombin 20210A variant with VT in cancer patients is not established. We genotyped 101 cancer patients with VT and 101 cancer patients without VT for these polymorphisms. Five cases and three controls were heterozygous for FVL, yielding an odds ratio of 1.7 (95% confidence interval (CI)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Factor V

Share to Neoplasms

Share to Polymorphism, Genetic

Share to Prothrombin

Share to Risk Factors

Share to Venous Thrombosis

Source

Identifiers

PMID: 15667542
DOI: 10.1111/j.1365-2141.2004.05327.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.PMID 15667542Read ↗

Prevalence of Factor V 1691 G-A (Leiden) and prothrombin G20210A polymorphisms and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Malignancies, prothrombotic mutations, and the risk of venous thrombosis.Semantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Prothrombotic genotypes and risk of venous thromboembolism in cancer.Semantic proximity Read ↗

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study.Semantic proximity Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

Polymorphisms of the coagulation system and risk of cancer.Semantic proximity Read ↗

Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.